SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Detecting pancreatic cancer through changes in body composition and metabolism

2.

Herpes virus-based vaccine shows promise in targeting tumors without side effects

3.

Distribution of fat could influence cancer risk, study suggests

4.

New First-Line Option for Advanced ALK-Positive Lung Cancer

5.

Traces of bacteria inside brain tumors may affect tumor behavior


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot